Data / Drug companies / Ergotamine Derivative
Ergotamine Derivative drugs: 4 drugs from 17 companies in the FDA NDC directory
Ergotamine Derivative is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 19 products in this class from 17 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on March 24, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 17Companies
- 19Products
- 4Drugs by generic name
Drugs in the Ergotamine Derivative class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Dihydroergotamine mesylate | 14 | 13 |
| Ergotamine tartrate and caffeine | 3 | 3 |
| Dihydroergotamine mesylate nasal | 1 | 1 |
| Ergotamine tartrate | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | 2 | injection | Generic drugs (ANDA) | March 31, 2023 |
| Trifluent Pharma, LLC | 2 | spray; tablet, film coated | Generic drugs (ANDA) | March 23, 2026 |
| Advagen Pharma Ltd | 1 | spray | Generic drugs (ANDA) | June 23, 2023 |
| Amneal Pharmaceuticals LLC | 1 | injection | New drug applications (NDA) | May 16, 2025 |
| Baxter Healthcare Corporation | 1 | injection, solution | Generic drugs (ANDA) | January 7, 2025 |
| Cintex Services, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | November 23, 2016 |
| Cipla USA Inc. | 1 | spray, metered | Generic drugs (ANDA) | May 23, 2020 |
| Cosette Pharmaceuticals, Inc. | 1 | suppository | Generic drugs (ANDA) | October 30, 1983 |
| Gland Pharma Limited | 1 | injection | Generic drugs (ANDA) | August 18, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | spray | Generic drugs (ANDA) | April 14, 2020 |
| Impel Pharmaceuticals LLC | 1 | spray, metered | New drug applications (NDA) | September 24, 2021 |
| Milla Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 30, 2021 |
| Oceanside Pharmaceuticals | 1 | spray | Authorized generics (NDA) | March 18, 2013 |
| Pangea Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | February 3, 2025 |
| Provepharm Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 30, 2021 |
| Satsuma Pharmaceuticals, Inc. | 1 | powder | New drug applications (NDA) | April 30, 2025 |
| Somerset Therapeutics, LLC | 1 | spray, metered | Generic drugs (ANDA) | March 24, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 4 | 21.1% |
| Spray | 4 | 21.1% |
| Injection, solution | 3 | 15.8% |
| Spray, metered | 3 | 15.8% |
| Tablet, film coated | 2 | 10.5% |
| Tablet | 1 | 5.3% |
| Powder | 1 | 5.3% |
| Suppository | 1 | 5.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.